Multiparametric Echocardiography and Cardiac Biomarkers in Pediatric Inflammatory Heart Diseases
NCT ID: NCT05911386
Last Updated: 2023-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2023-09-30
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These 3 inflammatory cardiac diseases have clinical, biological, and echographic similarities and differences. Nevertheless their modalities of monitoring, management and evolution are different. The investigators wish to retrospectively analyze biological and echocardiographic data of Kawasaki disease, myocarditis, PIMS patients managed at Nancy Children Hospital from January 1, 2017 to June 31, 2023.
The primary objective of this study is to identify, for these 3 pathologies, the prognostic factors of initiation of inotropic support.
The secondary objective is to identify the prognostic factors of degradation of ventricular function.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children
NCT04420468
Outcome of Clinical Phenotypes of Pediatric Myocarditis at Assiut University Children Hospital
NCT07175948
Efficacy of a Myocardial Panel in the Management and Treatment of Pediatric Myocarditis
NCT07086144
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy
NCT05112237
Cardiovascular Status of Children 5 Years After Kawasaki Disease
NCT03750123
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MYOCARDITIS
No intervention Study of available clinical, biological, and echocardiographic data
study of biological samples and echocardiographic data and link with need of hemodynamic support
observational study : there is no intervention
KAWASAKI
No intervention Study of available clinical, biological, and echocardiographic data
study of biological samples and echocardiographic data and link with need of hemodynamic support
observational study : there is no intervention
PIMS
No intervention Study of available clinical, biological, and echocardiographic data
study of biological samples and echocardiographic data and link with need of hemodynamic support
observational study : there is no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
study of biological samples and echocardiographic data and link with need of hemodynamic support
observational study : there is no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \< 18 years
Exclusion Criteria
* other complex heart disease
* management out of Nancy University children hospital center
0 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
BOSSER Gilles
chief of congenital and pediatric cardiology department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gilles BOSSER
Vandœuvre-lès-Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023PI058
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.